<SEC-DOCUMENT>0001104659-21-021965-index.html : 20210212
<SEC-HEADER>0001104659-21-021965.hdr.sgml : 20210212
<ACCEPTANCE-DATETIME>20210212162433
ACCESSION NUMBER:		0001104659-21-021965
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210212
DATE AS OF CHANGE:		20210212
GROUP MEMBERS:		NOVARTIS AG

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Poseida Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001661460
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				472846548
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91606
		FILM NUMBER:		21627941

	BUSINESS ADDRESS:	
		STREET 1:		9390 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-779-3100

	MAIL ADDRESS:	
		STREET 1:		9390 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVARTIS PHARMA AG
		CENTRAL INDEX KEY:			0001030617

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		STREET 2:		CH-4002
		CITY:			BASEL
		STATE:			V8
		BUSINESS PHONE:		212-830-2474

	MAIL ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		STREET 2:		CH-4002
		CITY:			BASEL
		STATE:			V8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVARTIS INC
		DATE OF NAME CHANGE:	19970114
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>tm216494d1_sc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: tm216494d1_sc13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm216494d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 1
<TEXT>
Document 2 - file: tm216494d1_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>tm216494d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 2
<TEXT>
Document 3 - file: tm216494d1_ex99-2.htm

</DOCUMENT>
</SEC-DOCUMENT>